SEVERE TOXIC REACTIONS ASSOCIATED WITH SULFAMETHOXYPYRIDAZINE (KYNEX)
Authors: J SALVAGGIO, F GONZALEZ
Journal: Annals of Internal Medicine (1959)

Article1 July 1959SEVERE TOXIC REACTIONS ASSOCIATED WITH SULFAMETHOXYPYRIDAZINE (KYNEX)J. SALVAGGIO, M.D., F. GONZALEZ, M.D.J. SALVAGGIO, M.D.Search for more papers by this author, F. GONZALEZ, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-51-1-60 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptThe ever-increasing problem of bacterial resistance to antibiotics has caused a "shift of the pendulum" back to the usage of sulfonamides in recent years. This fact has again brought into the spotlight the clinical toxicity of these chemotherapeutic agents. With the development of newer and more soluble compounds, renal toxicity has virtually ceased to exist, and there has been a marked decline of other types of reactions to these drugs. In his evaluation of the newer sulfonamides, Yow1has listed their injurious effects as follows: fever, 1.5%; dermatitis, 1.5%; gastrointestinal toxicity, 1.3%; blood dyscrasias, 0.18%; hepatitis, 0.1%; renal toxicity, anaphylaxis,...Bibliography1. Yow EM: A re-evaluation of sulfonamide therapy, Ann. Int. Med. 43: 323, 1955. LinkGoogle Scholar2. Lehr D: Clinical toxicity of sulfonamides, Ann. New York Acad. Sc. 69: 417, 1957. CrossrefMedlineGoogle Scholar3. RoepkeMarenMayer RRTHE: Experimental investigations of sulfamethoxypyridazine, Ann. New York Acad. Sc. 69: 457, 1957. CrossrefMedlineGoogle Scholar4. WalkerHamburger WFM: Clinical experiences with sulfamethoxypyridazine, Ann. New York Acad. Sc. 69: 509, 1957. CrossrefMedlineGoogle Scholar5. FriskWassen ARA: Clinical evaluation of sulfamethoxypyridazine, in Antibiotics annual, 1956-1957, 1957, Medical Encyclopedia, Inc., New York, p. 424. Google Scholar6. GriebleJackson HGGG: Prolonged treatment of urinary tract infections with sulfamethoxypyridazine, New England J. Med. 258: 1, 1958. CrossrefMedlineGoogle Scholar7. Vinnicombe J: Assessment of toxicity of a new sulfonamide, sulfamethoxypyridazine (Kynex), Antibiotic Med. 5: 474, 1958. MedlineGoogle Scholar8. LongHavillandEdwardsBliss PHJWLBEA: Toxic manifestations of sulfanilamide and its derivatives with reference to their importance in course of therapy, J. A. M. A. 115: 364, 1940. CrossrefGoogle Scholar9. Tisdale WA: Focal hepatitis, fever and skin rash following therapy with sulfamethoxypyridazine, a long-acting sulfonamide, New England J. Med. 258: 687, 1958. CrossrefMedlineGoogle Scholar10. HagemanBlake POFG: A specific febrile reaction to sulfanilamide (drug fever), J. A. M. A. 109: 642, 1937. CrossrefGoogle Scholar11. Carr EA: Allergy to drugs, New England J. Med. 245: 892, 1951. CrossrefMedlineGoogle Scholar12. Glaser GH: Psychotic reactions induced by corticotropin (ACTH) and cortisone, Psychosom. Med. 15: 280, 1953. CrossrefMedlineGoogle Scholar13. GoalkerSchein PJ: Psychic effects of ACTH and cortisone, Psychosom. Med. 15: 589, 1953. CrossrefMedlineGoogle Scholar14. RafettoNichols JFS: A nearly fatal reaction to sulfadiazine in a ten year old girl, involving skin, eyes and oropharynx, J. Pediat. 20: 753, 1942. CrossrefGoogle Scholar15. Bloom D: The danger of cutaneous reactions to sulfonamides, New York State J. Med. 43: 1499, 1943. Google Scholar16. van Vonnovan Raalte NCHG: Erythema exudativum (macular stage) with marked systemic involvement, Acta dermat.-venereol. 37: 382, 1957. MedlineGoogle Scholar17. D'Abrera VS: Erythema exudativum multiforme following sulphonamide therapy, M. J. Malaya 12: 427, 1957. MedlineGoogle Scholar18. Dardinsky VJ: Erythema multiforme bullosum following the use of sulfadiazine, Am. J. Clin. Path. 15: 28, 1945. CrossrefGoogle Scholar19. GreenbergMesser SIAL: Fatal bullous dermatitis following administration of sulfadiazine, J. A. M. A. 122: 944, 1943. CrossrefGoogle Scholar20. RoseDoolan JPD: A fatal case of erythema multiforme exudativum (Hebra) following sulfonamide therapy, Bull. Georgetown Univ. M. Center 1: 180, 1948. Google Scholar21. StevensJohnson AMFG: A new eruptive fever associated with stomatitis and ophthalmia: a report of two cases in children, Am. J. Dis. Child. 24: 526, 1922. CrossrefGoogle Scholar22. LindsayPrlinaBischoffBecker DGIAW: Cutaneous reactions due to sulfamethoxypyridazine, Arch. Derm. 78: 299, 1958. CrossrefGoogle Scholar23. JacksonGrieble GGHG: Sulfamethoxypyridazine: pharmacological observations and clinical use in the treatment of urinary tract infections, Ann. New York Acad. Sc. 69: 493, 1957. CrossrefMedlineGoogle Scholar24. HarrisRileyKnight APHDV: Sulfamethoxypyridazine in urinary tract infections, Arch. Int. Med. 100: 701, 1957. CrossrefGoogle Scholar25. BellIronsFurst BMGVWE: Prolonged urticaria after ingestion of sulfamethoxypyridazine, New England J. Med. 259: 585, 1958. CrossrefMedlineGoogle Scholar26. SchwartzNorton MJWS: Thrombocytopenia and leukopenia associated with the use of sulfamethoxypyridazine, J. A. M. A. 167: 457, 1958. CrossrefMedlineGoogle Scholar27. Short IA: Stevens-Johnson syndrome: report of five cases and discussion of etiology and treatment, Lancet 1: 290, 1957. CrossrefGoogle Scholar28. StanyonWarner JHWP: Mucosal respiratory syndrome, Canad. M. A. J. 53: 427, 1945. MedlineGoogle Scholar29. FinlandJolliffeParker MLF: Pneumonia and erythema multiforme exudativum, Am. J. Med. 4: 473, 1948. CrossrefMedlineGoogle Scholar30. MoreMcMillanDuff RHGCGL: The pathology of sulfonamide allergy in man, Am. J. Path. 22: 703, 1946. Google Scholar31. Rich AR: The role of hypersensitivity in periarteritis nodosa, Bull. Johns Hopkins Hosp. 71: 123, 1942. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: New Orleans, Louisiana*Received for publication February 9, 1959.From the Department of Medicine, Louisiana State University School of Medicine, and the Medical Service, Charity Hospital of Louisiana, New Orleans, Louisiana.†Product of Lederle Laboratories, Division, American Cyanamid Company.Requests for reprints should be addressed to John E. Salvaggio, M.D., Charity Hospital of Louisiana, 1532 Tulane Avenue, New Orleans, Louisiana. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byDrugs as etiologic factors in the Stevens-Johnson syndromeDevelopment of cataracts in dogs and rats from prolonged feeding of sulfaethoxypyridazineTHE STEVENS-JOHNSON SYNDROME AND LONG-ACTING SULPHONAMIDESNew drugsErythema Multiforme Exudativum MajorA REVIEW OF 31 CASES OF STEVENS‐JOHNSON SYNDROMERheumatism and Arthritis Review of American and English Literature of Recent Years (Fourteenth Rheumatism Review)CHARLEY J. SMYTH, M.D., F.A.C.P., ROGER L. BLACK, M.D., CHARLES L. CHRISTIAN, M.D., EPHRAIM P. ENGLEMAN, M.D., F.A.C.P., EDWARD C. FRANKLIN, M.D., DONALD F. HILL, M.D., F.A.C.P., JOSEPH L. HOLLANDER, M.D., F.A.C.P., HOWARD L. HOLLEY, M.D., F.A.C.P., JOHN G. MAYNE, M.D., WILLIAM M. MIKKELSEN, M.D., CHARLES L. SHORT, M.D., F.A.C.P., HUGH A. SMYTHE, M.D., F.R.C.P.(C), OTTO STEINBROCKER, M.D., HOWARD J. WEINBERGER, M.D.Fatal Exfoliative Dermatitis after SulfamethoxypyridazineThe Sulfonamides 1 July 1959Volume 51, Issue 1Page: 60-67KeywordsAdverse reactionsHospital medicineInflammationMedical servicesNauseaNecrosisRespiratory systemSulfonamideToxicityUrticaria ePublished: 1 December 2008 Issue Published: 1 July 1959 PDF downloadLoading ...